Skip to main content

Table 3 Descriptive analysis of the β S -haplotypes interference in the phenotypic expression of SCA patients

From: Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia

 

Parameters

 

Hb F (%)

TBARS (ng/mL)

TEAC (mM)

GST (U/mL)

CAT (U/mL)

GSH (μM)

Haplotypes (+HU)

n

      

Bantu/Bantu

2

1.95

1201.18

2.17

1.26

1742.95

1.30

Bantu/Benin

6*

17.42

1066.26

2.03

1.50

2294.01

0.62

Benin/Benin

1

5.2

1616.62

2.17

1.44

2278.17

1.10

Benin/Camer

0

-----

-----

-----

-----

-----

-----

Bantu/Atp1

0

-----

-----

-----

-----

-----

-----

Benin/Atp1

1

1.8

1524.30

2.20

1.20

1531.69

0.19

Benin/Atp2

1

8.4

1012.00

2.01

2.00

1084.51

0.22

Benin/Atp3

1

7.3

1216.92

2.10

1.92

1880.28

0.88

Atp2/Atp2

1

11

1308.00

1.97

1.51

1866.20

0.37

Haplotypes (−HU)

Bantu/Bantu

6*

6.78

2284.33

1.93

2.03

1656.10

0.77

Bantu/Benin

4*

6.68

1815.50

2.09

1.27

1842.43

0.84

Benin/Benin

1

2.1

1222.00

2.09

1.65

2570.42

0.74

Benin/Camer

1

4.8

934.00

1.90

2.00

996.48

0.70

Bantu/Atp1

1

3.2

1287.00

1.95

1.18

2017.61

0.87

Benin/Atp1

0

-----

-----

-----

-----

-----

-----

Benin/Atp2

0

-----

-----

-----

-----

-----

-----

Benin/Atp3

0

-----

-----

-----

-----

-----

-----

Atp2/Atp2

2

7.45

1576.00

1.77

1.45

1248.24

0.32

  1. (+HU): patients treated with HU; (−HU): patients not treated with HU; Camer: Cameroon; Atp: atypical.
  2. *Subgroups subject to statistical comparisons.